89 related articles for article (PubMed ID: 8537730)
1. [A case of ventricular tachycardia occurred during interferon therapy in chronic hepatitis C].
Omae A; Katayama K; Kakiuchi Y; Okada N; Hijioka Y; Nagai Y; Ito Y; Hagiwara H; Kasahara A; Hayashi N
Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1734-5. PubMed ID: 8537730
[No Abstract] [Full Text] [Related]
2. [Case of hepatocellular carcinoma due to interferon therapy of chronic hepatitis C].
Enomura H; Ogasawara M; Doi K; Endo T; Mori T; Matsuzaki O; Fujimoto Y; Takase K; Nakano T
Nihon Naika Gakkai Zasshi; 1997 Oct; 86(10):1961-3. PubMed ID: 9445884
[No Abstract] [Full Text] [Related]
3. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C.
Tambini R; Quattrini A; Fracassetti O; Nemni R
J Rheumatol; 1997 Aug; 24(8):1656-7. PubMed ID: 9263170
[No Abstract] [Full Text] [Related]
4. [Permanent hypothyroidism after interferon-alpha treatment in chronic hepatitis C].
Fernández Soto ML; Ventosa M; Luna V; Salmerón FJ
Med Clin (Barc); 1996 Jun; 107(2):76-7. PubMed ID: 8753901
[No Abstract] [Full Text] [Related]
5. [Hypothyroidism as a complication of the treatment of hepatitis C with interferon].
Gomollón García F; Simón Marco MA; Vela J; García López S; Fuentes Olmo J
An Med Interna; 1996 Sep; 13(9):438-40. PubMed ID: 9132035
[TBL] [Abstract][Full Text] [Related]
6. [How should hepatitis C be monitored? Monitoring of treated hepatitis C].
Larrey D
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S99-110. PubMed ID: 9161521
[No Abstract] [Full Text] [Related]
7. [Serum smooth muscle antibodies with anti-actin specificity appeared during treatment with interferon alpha].
Grimbert S; Mohib S; Johannet C; Trinchet JC; Beaugrand M
Gastroenterol Clin Biol; 1996; 20(4):404-5. PubMed ID: 8758511
[No Abstract] [Full Text] [Related]
8. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
[TBL] [Abstract][Full Text] [Related]
9. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
[TBL] [Abstract][Full Text] [Related]
10. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198
[TBL] [Abstract][Full Text] [Related]
11. [A case of interstitial pneumonia with chronic hepatitis C following interferon-alfa and sho-saiko-to therapy].
Sugiyama H; Nagai M; Kotajima F; Yoshizawa A; Kamimura M; Horiuchi T; Kudo K; Kabe J; Hayashi S; Umeda N
Arerugi; 1995 Jul; 44(7):711-4. PubMed ID: 7575138
[No Abstract] [Full Text] [Related]
12. Chronic paranoid psychosis and dementia following interferon-alpha treatment of hepatitis C: a case report.
Drozdz W; Borkowska A; Wilkosc M; Halota W; Dybowska D; Rybakowski JK
Pharmacopsychiatry; 2007 Jul; 40(4):146-8. PubMed ID: 17694476
[TBL] [Abstract][Full Text] [Related]
13. Case of mania induced by withdrawal of interferon-alpha in a patient affected by bipolar disorder.
Rossi A; Renzetti D; D'Albenzio L; Gianfelice D; Kalyvoka A; Rinaldi O
Psychiatry Clin Neurosci; 2002 Dec; 56(6):647-8. PubMed ID: 12485309
[No Abstract] [Full Text] [Related]
14. Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature.
Fukuyama S; Kajiwara E; Suzuki N; Miyazaki N; Sadoshima S; Onoyama K
Am J Gastroenterol; 2000 Jan; 95(1):310-2. PubMed ID: 10638610
[No Abstract] [Full Text] [Related]
15. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
Christensen UB; Krogsgaard K
Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
[No Abstract] [Full Text] [Related]
16. [Efficacy of interferon re-therapy and its adaptation in chronic hepatitis C].
Matsuo S; Ohnishi K; Fujiwara K
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1012-6. PubMed ID: 7563658
[No Abstract] [Full Text] [Related]
17. Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study.
Gelzer AR; Kraus MS; Rishniw M; Hemsley SA; Moïse NS
J Vet Cardiol; 2010 Aug; 12(2):93-106. PubMed ID: 20663731
[TBL] [Abstract][Full Text] [Related]
18. Steroid-responsive demyelinating motor neuropathy with conduction block associated with hepatitis C infection and treatment with interferon alpha.
Couto M; Conceição I; de Carvalho M
J Peripher Nerv Syst; 2006 Dec; 11(4):353-4. PubMed ID: 17117944
[No Abstract] [Full Text] [Related]
19. Interferon-induced obsessive-compulsive disorder.
DeRosse P; Szeszko PR; Malhotra AK
Gen Hosp Psychiatry; 2006; 28(4):357-8. PubMed ID: 16814637
[No Abstract] [Full Text] [Related]
20. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
